Biological safety and compliance with global standards are critical when developing in-vitro diagnostic medical devices. One of the most important steps in this process is obtaining a BIS Certificate for Biological Evaluation of Invitro Diagnostic Medical Devices. Without this certification, you risk non-compliance, market restrictions, and potentially unsafe devices.
This article will address your questions about BIS certification for Biological Evaluation Of Invitro Diagnostic Medical Devices (MHD-19), explain its significance, and guide you through the process in an easy-to-understand manner.
By the end, you’ll have a clear understanding of how to secure this certification for your IVD medical devices and maintain compliance in the ever-evolving healthcare sector.
Table of Contents
ToggleWhat Is BIS Certification And Why Is It Important For IVD Medical Devices?
A BIS Certificate for Biological Evaluation Of Invitro Diagnostic, issued by the Bureau of Indian Standards. It ensures your product meets prescribed safety, quality, and performance standards. For IVD medical devices, biological evaluation is critical to demonstrate that they are safe for human use and won’t cause adverse biological effects.
Without BIS certification for Medical Devices, your devices may fail to enter the market, resulting in significant setbacks. The certificate is not just a legal requirement but also a trust-building factor for your customers. Hence, we highly recommend you get BIS Certificate for your Invitro Medical Devices to stay away from any sort of legal trouble.
Who Needs BIS Certificate For Biological Evaluation Of Invitro Diagnostic?
Manufacturers and importers of Invitro diagnostic devices intended for the Indian market are required to secure BIS certification. Such as Domestic manufacturers who produce IVD devices for local or international markets, foreign manufacturers exporting IVD devices to India or importers and distributors bringing IVD devices into India.
If your business falls into one of these categories, obtaining the BIS Certificate is essential to ensure your products comply with Indian standards.
Also Read: BIS Certificate For Health Informatics
Why Is Biological Evaluation Critical For IVD Devices?
Biological evaluation ensures that your IVD device is biocompatible and does not provoke harmful biological responses. This is crucial because IVD devices may come into contact with human tissues or fluids.
Biological risks can include:
- Cytotoxicity: Damaging cells.
- Sensitization: Causing allergic reactions.
- Toxicity: Introducing harmful substances into the body.
The evaluation process follows international guidelines like ISO 10993, ensuring that the device is safe and effective for its intended use.
Process To Obtain BIS Certificate For Biological Evaluation Of In-Vitro Diagnostic Medical Devices
We have listed the step-by-step process for obtaining BIS Certification for Biological Evaluation of Invitro Diagnostic Medical Devices (MHD-19).
- Determine Applicability: Verify if your IVD device requires BIS certification under standards like IS 10993 for biological evaluation.
- Conduct Biological Testing: Perform tests such as cytotoxicity, sensitization, and toxicity in BIS-accredited laboratories to ensure biocompatibility.
- Prepare Documentation: Accurate and comprehensive documentation is essential for a successful application. Compile essential documents such as product technical files, certified test reports, ISO 13485 or QMS certifications, etc.
- Submit the Application: Apply online via the BIS portal or through an authorized office, attaching documents and paying fees.
- Undergo Testing and Inspection: BIS may review test reports, inspect facilities, or test product samples for compliance.
- Approval and Certification: If all requirements are met, BIS grants certification, allowing you to display the BIS Standard Mark.
Documents Required To Get BIS Certificate For Biological Evaluation Of Invitro Diagnostic
To obtain a BIS Certificate for Biological Evaluation of Invitro Diagnostic Medical Devices, there are several documents which are required, listed below:
- Application Form
- Product Specifications
- Test Reports
- Manufacturing Details
- QMS Certification
- Importer/Distributor Agreement
- Labels and Markings
- Declaration of Conformity
- Authorised Signatory Details
Also Read: BIS Certificate For Electromedical Diagnostic Imaging And Radiotherapy Equipment
List Of Standards For Biological Evaluation Of Invitro Diagnostic Medical Devices
This table outlines key standards of biological evaluation, safety, and testing of medical devices:
SI. No. | IS No. | TITLE |
---|---|---|
1 | IS 12572: Part 1: 1994/ISO 10993-1 | Biological Evaluation of Medical Devices – Part 1: Guidance on Selection of Tests |
(1 Revision) | ||
2 | IS 12572: Part 11: 1990 | Guide for evaluation of medical devices for biological hazards: Part 11 Method of test for eye irritation |
3 | IS 12572: Part 3: 1988 | Guide for evaluation of medical devices for biological hazards: Part 3 Method of testing by tissue implantation |
4 | IS 12572: Part 4: 2016/ISO 10993-4: 2002 | Biological evaluation of medical devices: Part 4 selection of tests for interaction with blood |
(1 Revision) | ||
5 | IS 12572: Part 5: 1988 | Guide for evaluation of medical devices for biological hazards: Part 5 method of test for intracutaneous reactivity of extracts from medical devices |
6 | IS 12572: Part 6: 1988 | Guide for evaluation of medical devices for biological hazards: Part 6 method of test for systemic toxicity: assessment of pyrogenicity in rabbits of extracts from medical devices |
7 | IS 12572: Part 7: 1988 | Guide for evaluation of medical devices for biological hazards: Part 7 Methods of test for sensitization: assessment of the potential of medical devices to produce delayed contact dermatitis |
8 | IS 12572: Part 8: 1988 | Guide for evaluation of medical devices for biological hazards: Part 8 method of test for skin irritation of extracts from medical devices |
9 | IS 12572: Part 9: 1988 | Guide for evaluation of medical devices for biological hazards: Part 9 Method of test for skin irritation by solid medical devices |
10 | IS/IEC 61010: Part 1: 2010 | Safety requirements for electrical equipment for measurement, control, and laboratory use: Part 1 general requirements |
11 | IS/IEC 61010: Part 2-081 :2009/IEC 61010: Part 2-081 :2009 | Safety requirements for electrical equipment for measurement, control and laboratory use: Part 2 – 081 particular requirements for automatic and semiautomatic laboratory equipment for analysis and other purposes |
12 | IS/IEC/TS 10993: Part 19 :2006/ISO/TS 109993-19: 2006 | Biological Evaluation of Medical Devices Part 19 Physico-Chemical, Morphological and Topographical Characterization of Materials |
13 | IS/ISO 10993: Part 1: 2009/ISO 10993-1: 2009 | Biological evaluation of medical devices: Part 1 evaluation and testing within a risk management process |
14 | IS/ISO 10993: Part 10 :2010/ISO 10993-10:2010 | Biological evaluation of medical devices: Part 10 tests for irritation and skin sensitization |
15 | IS/ISO 10993: Part 11 :2017/ISO 10993-11: 2017 | Biological evaluation of medical devices: Part 11 tests for systemic toxicity |
16 | IS/ISO 10993: Part 13 :2010/ISO 10993-13:2010 | Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices |
17 | IS/ISO 10993: Part 14 :2001/ISO 10993-14:2001 | Biological evaluation of medical devices — Part 14: Identification and quantification of degradation products from ceramics |
18 | IS/ISO 10993: Part 15 :2000/ISO 10993-15:2000 | Biological evaluation of medical devices: Part 15 Identification and quantification of degradation products from metals and alloys |
19 | IS/ISO 10993: Part 16 :2017/ISO 10993-16: 2017 | Biological evaluation of medical devices: Part 16 toxicokinetic study design for degradation products and leachables |
20 | IS/ISO 10993: Part 17 :2002/ISO 10993-17: 2002 | Biological evaluation of medical devices: Part 17 establishment of allowable limits for leachable substances |
21 | IS/ISO 10993: Part 2: 2006/ISO 10993-2:2006 | Biological Evaluation of Medical Devices Part 2 Animal Welfare Requirements ( First Revision ) |
22 | IS/ISO 10993: Part 3: 2014/ISO 10993-3: 2014 | Biological evaluation of medical devices: Part 3 tests for genotoxicity, carcinogenicity and reproductive toxicity (First Revision) |
23 | IS/ISO 10993: Part 4: 2017/ISO 10993-4: 2017 | Biological evaluation of medical devices: Part 4 Selection of tests for interactions with blood |
24 | IS/ISO 10993: Part 5: 2009/ISO 10993-5 2009 | Biological evaluation of medical devices: Part 5 tests for in vitro cytotoxicity |
25 | IS/ISO 10993: Part 6: 2016/ISO 10993-6: 2016 | Biological evaluation of medical devices: Part 6 tests for local effects after implantation |
26 | IS/ISO 10993: Part 7: 2018/ISO 10993-7:2008 | Biological evaluation of medical devices: Part 7 Ethylene oxide sterilization residuals |
27 | IS/ISO 10993: Part 9: 2009/ISO 10993-9:2009 | Biological evaluation of medical devices: Part 9 Framework for identification and quantification of potential degradation products |
28 | IS/ISO 13022: 2012/ISO 13022:2012 | Medical products containing viable human cells – Application of risk management and requirements for processing practices |
29 | IS/ISO 14155: 2011/ISO 14155:2011 | Clinical investigation of medical devices for human subjects – Good clinical practice |
30 | IS/ISO 22442: Part 1: 2015/ISO 22442-1 2015 | Medical devices utilizing animal tissues and their derivatives: Part 1 application of risk management |
31 | IS/ISO 22442: Part 2: 2015/ISO 22442-2:2007 | Medical devices utilizing animal tissues and their derivatives: Part 2 controls on sourcing, collection and handling |
32 | IS/ISO 22442: Part 3 2007/ISO 22442-3:2007 | Medical devices utilizing animal tissues and their derivatives- Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE ) agents |
33 | IS/ISO 7405: 2008/ISO 7405:2008 | Dentistry – Evaluation of biocompatibility of medical devices used in dentistry |
34 | IS/ISO/TR 10993 Part 22 :2017/ISO/TR 10993-22:2017 | Biological Evaluation of Medical Devices Part 22 Guidance on Nanomaterials |
35 | IS/ISO/TR 15499: 2016/ISO/TR 15499 2016 | Biological evaluation of medical devices – Guidance on the conduct of biological evaluation within a risk management process |
36 | IS/ISO/TR 22442: Part 4 :2010/ISO/TR 22442-4:2010 | Medical Devices Utilizing Animal Tissues and their Derivatives Part 4 Principles for Elimination and/or Inactivation of Transmissible Spongiform Encephalopathy (TSE) Agents and Validation Assays for those Processes |
37 | IS/ISO/TR 37137: 2014/ISO/TR 37137:2014 | Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants |
38 | IS/ISO/TS 10993 Part 20 :2006/ISO/TS 10993-20:2006 | Biological evaluation of medical devices — Part 20: Principles and methods for immunotoxicology testing of medical devices |
Is BIS Certification Mandatory For All IVD Devices?
Yes, BIS certification is mandatory for IVD devices entering the Indian market to ensure compliance with safety standards.
What Happens If My Device Fails Biological Evaluation?
If a device fails biological evaluation, you must address the issues, retest, and reapply for BIS certification.
Can BIS Certification Be Transferred Between Products?
No, BIS certification is product-specific. Each device must undergo its own evaluation and certification process.